SAMR punishes drug wholesalers for price-fixing cancer treatment injections

China’s antitrust watchdog has fined two drug wholesalers €7.5 million for price-fixing and dividing the market for a cancer treatment injection, continuing its aggressive enforcement in the pharmaceutical sector.

Unlock unlimited access to all Global Competition Review content